- $4.42bn
- $7.76bn
- $2.37bn
- 62
- 70
- 78
- 80
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,653 | 1,530 | 1,809 | 2,578 | 2,372 |
Cost of Revenue | |||||
Gross Profit | 965 | 993 | 1,034 | 1,119 | 1,237 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 1,357 | 1,227 | 1,498 | 2,228 | 1,994 |
Operating Profit | 295 | 304 | 310 | 350 | 378 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 230 | 238 | 247 | 268 | 272 |
Provision for Income Taxes | |||||
Net Income After Taxes | 187 | 196 | 206 | 222 | 231 |
Net Income Before Extraordinary Items | |||||
Net Income | 187 | 196 | 206 | 222 | 231 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 187 | 196 | 206 | 222 | 231 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.51 | 3.68 | 3.85 | 4.08 | 4.14 |
Dividends per Share |